Pfizer Inc. (LON:0Q1N)

London flag London · Delayed Price · Currency is GBP · Price in USD
25.06
+0.53 (2.16%)
At close: Aug 13, 2025
-12.23%
Market Cap 105.42B
Revenue (ttm) 46.55B
Net Income (ttm) 7.84B
Shares Out n/a
EPS (ttm) 1.38
PE Ratio 13.45
Forward PE 9.04
Dividend 1.31 (5.35%)
Ex-Dividend Date Jul 25, 2025
Volume 37,681
Average Volume 60,171
Open 24.62
Previous Close 24.53
Day's Range 24.60 - 25.17
52-Week Range 20.77 - 30.41
Beta 0.44
RSI 57.10
Earnings Date Aug 5, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Industry Pharmaceutical Preparations
Founded 1849
Employees 81,000
Stock Exchange London Stock Exchange
Ticker Symbol 0Q1N
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements

News

There is no news available yet.